Value Added Technology Co., Ltd. (KOSDAQ:043150)
21,100
+450 (2.18%)
Jun 5, 2025, 3:30 PM KST
Value Added Technology Revenue
Value Added Technology had revenue of 101.32B KRW in the quarter ending March 31, 2025, with 7.52% growth. This brings the company's revenue in the last twelve months to 392.28B, up 1.05% year-over-year. In the year 2024, Value Added Technology had annual revenue of 385.19B with 0.06% growth.
Revenue (ttm)
392.28B
Revenue Growth
+1.05%
P/S Ratio
0.80
Revenue / Employee
1.35B
Employees
291
Market Cap
313.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 385.19B | 249.51M | 0.06% |
Dec 31, 2023 | 384.95B | -10.11B | -2.56% |
Dec 31, 2022 | 395.06B | 56.08B | 16.54% |
Dec 31, 2021 | 338.98B | 94.67B | 38.75% |
Dec 31, 2020 | 244.31B | -27.39B | -10.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |